Home › Kanser ng Endometrium › California › San Diego
Pag-aaral pangklinika para sa Kanser ng Endometrium sa San Diego, CA
16 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Diego (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- UC San Diego Medical Center - Hillcrest, San Diego
- Sharp Memorial Hospital, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
- Research Site, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- University of California, San Diego, La Jolla · 11 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- Scripps Health, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Nagre-recruitPhase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi ang layo
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Nagre-recruitPhase 3
- Research Site, La Jolla · 11 mi ang layo
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Nagre-recruitPhase 1
- UC San Diego Moores Cancer Center, San Diego
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Nagre-recruitPhase 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Nagre-recruitPhase 3
- Research Site, La Jolla · 11 mi ang layo
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Investigative Site #101, San Diego
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Nagre-recruitPhase 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, La Jolla · 11 mi ang layo
A Beta-only IL-2 ImmunoTherapY Study
Nagre-recruitPhase 1/2
- Sharp Memorial Hospital, San Diego
Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod
- Houston, TX68 pag-aaral
- New York City, NY52 pag-aaral
- Boston, MA50 pag-aaral
- Arlington, VA39 pag-aaral
- Nashville, TN38 pag-aaral
- Los Angeles, CA34 pag-aaral
- St. Louis, MO29 pag-aaral
- Philadelphia, PA28 pag-aaral
- San Antonio, TX27 pag-aaral
- Columbus, OH25 pag-aaral
- Oklahoma City, OK25 pag-aaral
- Chicago, IL25 pag-aaral
Iba pang pag-aaral sa San Diego
- Non-Small Cell Lung Cancer48 pag-aaral
- Kanser sa Suso41 pag-aaral
- Kanser (lahat ng uri)32 pag-aaral
- Kanser sa Prostate31 pag-aaral
- Metastatic Cancer30 pag-aaral
- Colorectal Cancer25 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Kanser sa Pancreas24 pag-aaral
- Kanser sa Baga23 pag-aaral
- Obesity23 pag-aaral
- Pagkabigo ng Puso23 pag-aaral
- Depression21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.